Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

for
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia,
Location: Fort Myers FL, Mayfield Heights OH, Cleveland OH,
Sponsor: Frantz Viral Therapeutics, LLC

Sex: Female

Age: 25 - 70+

Code: NCT04098744

Phase 2, Recruiting

PCOM2 - The Physician Communication Intervention, Version 2.0

for
HPV Infection, Preventive Health Services
Location: Wichita KS, Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 9 - 17

Code: NCT05336240

Recruiting

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

for
Gastric Cancer, Gastrointestinal Cancer, HER2 Gene Mutation
Location: Philadelphia PA, Buffalo NY, Palo Alto CA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT05274048

Phase 1, Recruiting

Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT06534125

Recruiting

DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

for
HER2-negative Breast Cancer,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06388122

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

for
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma,
Location: Jacksonville FL, Grand Forks ND
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05969860

Phase 2, Recruiting

A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women

for
HIV Prevention, PrEP, Women, Intimate Partner Violence (IPV)
Location: Baltimore MD
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: Female

Age: 18+

Code: NCT06703060

Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Florham Park NJ, Weston FL, Ann Arbor MI, Cincinnati OH,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

for
Oropharyngeal Cancer, HPV-Related Carcinoma
Location: Pittsburgh PA, Tampa FL, Omaha NE
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06305676

Recruiting

Influenza Immunization in Adults Over Age 75

for
Influenza, Immunization, Older Adults, Over Age 75
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 70+

Code: NCT02200276

Recruiting

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

for
Metastatic HER2-Negative Breast Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05770531

Phase 2, Recruiting

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

for
Influenza a, Influenza B, RSV, COVID 19
Location: Pittsburgh PA, McAllen TX, Henderson NV
Sponsor: DiaSorin Molecular LLC

Sex: All

Age: 0+

Code: NCT06672692

Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

for
Breast Cancer, HER2-positive Breast Cancer,
Location: Hershey PA, Rochester NY, Chicago IL, Madison WI
Sponsor: Ruth O'Regan

Sex: All

Age: 18+

Code: NCT04886531

Phase 2, Recruiting

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

for
COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 18 - 70+

Code: NCT07287137

Phase 4, Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Richmond VA, Chapel Hill NC, Miami FL, Pittsburgh PA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

for
Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive,
Location: Columbia MD, Fairfax VA, Nashville TN, New Braunfels TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07683754

Phase 3, Recruiting

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07578116

Phase 3, Recruiting

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

for
Metastatic Breast Cancer, HER2-negative Breast Cancer,
Location: Indianapolis IN, Omaha NE, Longmont CO, Vancouver,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 0+

Code: NCT06590857

Phase 1, Phase 2, Recruiting

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

for
Hormone Receptor Positive, HER2-low or HER2-ultralow,
Location: New York NY
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07701941

Phase 1, Phase 2, Recruiting

A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

for
Chronic Pruritus of Unknown Origin
Location: The Bronx NY, Quebec, Miami FL, North Charleston SC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07700056

Phase 3, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial